Skillnad mellan versioner av "Referenser-infektioner i övre luftvägarna"

Från Referensmetodik för laboratoriediagnostik
Hoppa till navigering Hoppa till sök
(Skapade sidan med '''Till innehållsförteckningen för Referensmetodik: Övre luftvägsinfektioner (ÖLI)'' ---- == REFERENSER == *1. Johnson CC, Tunkel AR. Viridans streptococet and groups …')
 
 
(En mellanliggande sidversion av samma användare visas inte)
Rad 4: Rad 4:
 
== REFERENSER ==
 
== REFERENSER ==
  
*1. Johnson CC, Tunkel AR. Viridans streptococet and groups C and G streptococci. In: Mandell, Douglas and Bennet. Principles and Practice of Infectious Diseaseas.
+
*1. Johnson CC, Tunkel AR. Viridans streptococcal and groups C and G streptococci. In: Mandell, Douglas and Bennet. Principles and Practice of Infectious Diseaseas. (Eda: Mandell, Bennen, Dolin), 4th ed 1995, Chapter 181, p 1853-1854.
(Eda: Mandell, Bennen, Dolin), 4th ed 1995, Chapter 181, p 1853-1854,
 
*2. Cimola N, Elford RW, Ban L, Anand C, Berger P. Do the -hemoIytic non-group A streptococci cause pharyngitis?. Rev Infect Die 1988;1O:5t7-60l. 3,
 
*3. Daum RS, Nachman fl’, Latch CD, Tenover FC. Nosocomial epiglottitis associated with gentamicin- and cephalosporin resistant Stretptococcus pneumoniae bacteriemia. J Clin Microbiol 1994;32:246-248
 
  
'''EJ korrekturläst'''
+
*2. Cimola N, Elford RW, Ban L, Anand C, Berger P. Do the beta-hemolytic non-group A streptococci cause pharyngitis?. Rev Infect Die 1988;10:597-60l.
*4. puhaktea EJ. Akut otit- en problem för barnet, familjen och sjnkvärdeai. Nordisk Medicin 1991;t06:293-296.
+
 
*5. Austnian R, Howie VM, Ploussard aM. The baeteriology of pnenmoeOccai otal’s media. Johns Hopkins Med J. 1977:141:104-tt.  
+
*3. Daum RS, Nachman H, Latch CD, Tenover FC. Nosocomial epiglottitis associated with gentamicin- and cephalosporin resistant ''Streptococcus pneumoniae'' bacteriemia. J Clin Microbiol 1994;32:246-248.
*6. Looa BO, Bematein IM, Deyja DM, Murphy TF. Dieldnsota DP. Determinatioti of  
+
the epidemiology and tranamission of nontypeable Hcoamophilus iofluenzae an children with otitis medla by comparaton of total genomic DNA restrietton fangerprines. tnfeet Immun 1989;57:275 1-2757.  
+
*4. Puhaktea EJ. Akut otit- ett problem för barnet, familjen och sjukvården. Nordisk Medicin 1991;106:293-296.
*7. Dickinaon DP, Lcoa BO, Dryja DM, Bernaceita JM. Reateiction fragment mapping of Brct,ahasnellaa catarrhali,: A new tool for soadying the epidemiology of th,a middte ear pathogen. 3 tnfect Dta 1988;t58:205-208.
+
 
*8. K, Rydelt R. Acttte enaatoiditis. tnfluenee of antibiotic trealnoent on the bacteriat speotnam. Acta Otolaryngol (Stockh) l986;t02:52-56.  
+
*5. Austrian R, Howie VM, Ploussard JM. The bacteriology of pneumococcal otitis media. Johns Hopkins Med J. 1977:141:104-11.
*9. RePon from a Seanditaaviata Study Group Loracarbef versus doxycyetine in the ereatment of acute bactertal naaxillary sinatitis. J Antimierob Chemolher 19933t:949-961.
+
*10. Almadort 0, Bastiantaat L, Btstont F, Mannzi M et al. Microbtal flora of lIte and paranasal sinuses in chronte maxttlary sinusatts. Rltinology, 1956:4:257-265
+
*6. Loos BG, Bernstein IM, Dryja DM, Murphy TF. Dickinson DP. Determination of the epidemiology and transmission of nontypeable ''Haemophilus influenzae'' an children with otitis media by comparision of total genomic DNA restriction fingerprints. Infect Immun 1989;57:2751-2757.
 +
 +
*7. Dickinson DP, Loos BG, Dryja DM, Bernstein JM. Restriction fragment mapping of ''Branhamella catarrhalis'',: A new tool for studying the epidemiology of this middle ear pathogen. J Infect Dis 1988;158:205-208.
 +
 
 +
*8. K, Rydelt R. Acute mastoiditis. Influence of antibiotic treatment on the bacterial spectrum. Acta Otolaryngol (Stockh) l986;102:52-56.
 +
 +
*9. Report from a Scandinavian Study Group. Loracarbef versus doxycycline in the treatment of acute bacterial maxillary sinusitis. J Antimicrob Chemother 1993;31:949-961.
 +
 
 +
*10. Almadori G, Bastianini L, Bistoni F, Manurizi M et al. Microbial flora of the nose and paranasal sinuses in chronic maxillary sinusitis. Rhinology, 1986;4:257-265.
  
  
 
[[Kategori:ÖLI]]
 
[[Kategori:ÖLI]]

Nuvarande version från 14 december 2009 kl. 16.21

Till innehållsförteckningen för Referensmetodik: Övre luftvägsinfektioner (ÖLI)


REFERENSER[redigera]

  • 1. Johnson CC, Tunkel AR. Viridans streptococcal and groups C and G streptococci. In: Mandell, Douglas and Bennet. Principles and Practice of Infectious Diseaseas. (Eda: Mandell, Bennen, Dolin), 4th ed 1995, Chapter 181, p 1853-1854.
  • 2. Cimola N, Elford RW, Ban L, Anand C, Berger P. Do the beta-hemolytic non-group A streptococci cause pharyngitis?. Rev Infect Die 1988;10:597-60l.
  • 3. Daum RS, Nachman H, Latch CD, Tenover FC. Nosocomial epiglottitis associated with gentamicin- and cephalosporin resistant Streptococcus pneumoniae bacteriemia. J Clin Microbiol 1994;32:246-248.
  • 4. Puhaktea EJ. Akut otit- ett problem för barnet, familjen och sjukvården. Nordisk Medicin 1991;106:293-296.
  • 5. Austrian R, Howie VM, Ploussard JM. The bacteriology of pneumococcal otitis media. Johns Hopkins Med J. 1977:141:104-11.
  • 6. Loos BG, Bernstein IM, Dryja DM, Murphy TF. Dickinson DP. Determination of the epidemiology and transmission of nontypeable Haemophilus influenzae an children with otitis media by comparision of total genomic DNA restriction fingerprints. Infect Immun 1989;57:2751-2757.
  • 7. Dickinson DP, Loos BG, Dryja DM, Bernstein JM. Restriction fragment mapping of Branhamella catarrhalis,: A new tool for studying the epidemiology of this middle ear pathogen. J Infect Dis 1988;158:205-208.
  • 8. K, Rydelt R. Acute mastoiditis. Influence of antibiotic treatment on the bacterial spectrum. Acta Otolaryngol (Stockh) l986;102:52-56.
  • 9. Report from a Scandinavian Study Group. Loracarbef versus doxycycline in the treatment of acute bacterial maxillary sinusitis. J Antimicrob Chemother 1993;31:949-961.
  • 10. Almadori G, Bastianini L, Bistoni F, Manurizi M et al. Microbial flora of the nose and paranasal sinuses in chronic maxillary sinusitis. Rhinology, 1986;4:257-265.